Ann: Change of Company Name-MNQ.AX, page-44

First 44 Last

Share
Profile

Follow
longwalker

638 Posts.

39

30/09/16

11:56

Post #: 19535906
Share

Originally posted by Quinten ↑

Thanks for taking the time to reply da_whippet and longwalker.
Very insightful, better than just comparing it to RAP, like there's some medical app boom happening?

I guess if ePAT can determine whether a preverbal child is in pain or upset via other reasons as you put it (hungry or cold etc), does the tech need more R&D to determine the different "crying expressions"?
For my kids they all look the same just crying at the top of their lungs with tears rolling down lol.

I assume the tech needs updating as dementia people don't cry like babies. Seems like a complex problem, which needs more clinical trails to determine the many crying expressions of babies and toddlers.

But then of course they might open up a whole new market, one that all parents dream of. Imagine an app that can determine whether your baby is hungry or cold or has wind or wants to be carried, etc etc..now that would be a bigger market than just determining whether they're in pain which usually a thermometer and physical inspection will do most parents.

But of course this need more money in R&D, so lets hope that can commercialise the product for the dementia market soon. Then they can start getting revenue as you stated Longwalker, but how much can they get with only $500k budgeted for S&M? Enough i hope, or a CR might cap the SP in the future.

Expand

RAP did a raise of $12M at 20c and the stock kept going , it all depends if the CR is used to fund growth, then sometimes the metric of share price increases to justify the higher market cap

MNQ Price at posting: 0.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

There are more pages in this discussion • 2 more messages in this thread...

First 44 Last

Add MNQ (ASX) to my watchlist

Ann: Change of Company Name-MNQ.AX, page-44

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Banshee's historic trenches prove rich in antimony and gold for GDM

Featured News